Viewing StudyNCT06207734



Ignite Creation Date: 2024-05-06 @ 7:59 PM
Last Modification Date: 2024-10-26 @ 3:18 PM
Study NCT ID: NCT06207734
Status: RECRUITING
Last Update Posted: 2024-04-12
First Post: 2024-01-03

Brief Title: Discontinuation of CDK46 Inhibitors in Patients With Metastatic HR Positive HER2 Negative Breast Cancer
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Endocrine therapy View
Metastatic HR positive HER2 negative breast cancer View
CDK46 inhibitors View